BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 21839301)

  • 1. Combination therapy with an endothelin-1 receptor antagonist (bosentan) and a phosphodiesterase V inhibitor (sildenafil) for the management of severe digital ulcerations in systemic sclerosis.
    Moinzadeh P; Hunzelmann N; Krieg T
    J Am Acad Dermatol; 2011 Sep; 65(3):e102-e104. PubMed ID: 21839301
    [No Abstract]   [Full Text] [Related]  

  • 2. Low-dose combination therapy of severe digital ulcers in diffuse progressive systemic sclerosis with the endothelin-1 receptor antagonist bosentan and the phosphodiesterase V inhibitor sildenafil.
    Ambach A; Seo W; Bonnekoh B; Gollnick H
    J Dtsch Dermatol Ges; 2009 Oct; 7(10):888-91. PubMed ID: 19302565
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oral sildenafil in skin ulcers secondary to systemic sclerosis.
    Della Rossa A; Doveri M; D'Ascanio A; Tavoni A; Consensi A; Neri R; Bazzichi L; Bombardieri S
    Scand J Rheumatol; 2011; 40(4):323-5. PubMed ID: 21639825
    [No Abstract]   [Full Text] [Related]  

  • 4. Bosentan and sildenafil: successful treatment in a sclerodermic patient with refractory ulcers.
    Catarsi E; Doveri M; Tavoni A
    Reumatismo; 2013 May; 65(2):79-81. PubMed ID: 23877412
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combination therapy with bosentan and sildenafil in Eisenmenger syndrome: a randomized, placebo-controlled, double-blinded trial.
    Iversen K; Jensen AS; Jensen TV; Vejlstrup NG; Søndergaard L
    Eur Heart J; 2010 May; 31(9):1124-31. PubMed ID: 20202971
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Efficacy of combination therapy with bosentan and sildenafil for refractory pulmonary arterial hypertension associated with fibrotic lung in systemic sclerosis].
    Gocho K; Sugino K; Ota H; Kusano E; Takai Y; Homma S
    Nihon Kokyuki Gakkai Zasshi; 2010 Oct; 48(10):786-90. PubMed ID: 21066870
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Severe refractory fingertip ulcerations in a patient with scleroderma: successful treatment with sildenafil.
    Colglazier CL; Sutej PG; O'Rourke KS
    J Rheumatol; 2005 Dec; 32(12):2440-2. PubMed ID: 16331780
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acute effect of sildenafil is maintained in pulmonary arterial hypertension patients chronically treated with bosentan.
    Hatano M; Yao A; Kinugawa K; Hirata Y; Nagai R
    Int Heart J; 2011; 52(4):233-9. PubMed ID: 21828950
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Systemic sclerosis: paths into the future].
    Guillevin L
    Presse Med; 2006 Dec; 35(12 Pt 2):1892-3. PubMed ID: 17159714
    [No Abstract]   [Full Text] [Related]  

  • 10. Combination of sildenafil and bosentan for pulmonary hypertension in a human ex vivo model.
    Ried M; Potzger T; Neu R; Sziklavari Z; Szöke T; Liebold A; Hofmann HS; Hoenicka M
    Cardiovasc Drugs Ther; 2014 Feb; 28(1):45-51. PubMed ID: 24193244
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Pharmacological treatment of pulmonary hypertension at a turning point].
    Watanabe H
    Nihon Yakurigaku Zasshi; 2014 Apr; 143(4):165-72. PubMed ID: 24717603
    [No Abstract]   [Full Text] [Related]  

  • 12. Addition of sildenafil in patients with pulmonary arterial hypertension with inadequate response to bosentan monotherapy.
    Porhownik NR; Al-Sharif H; Bshouty Z
    Can Respir J; 2008; 15(8):427-30. PubMed ID: 19107243
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Sildenafil in the treatment of digital ulcers in patients with systemic sclerosis].
    Cairoli E; Garra V; Martínez M
    Actas Dermosifiliogr; 2009 Nov; 100(9):830-2. PubMed ID: 19889312
    [No Abstract]   [Full Text] [Related]  

  • 14. [Combined treatment of patients with erectile dysfunction and urination disorders].
    Kamalov AA; Osmolovskiĭ BE; Okhobotov DA; Khodyreva LA; Takhiradze TB; Takhiradze AM; Gevorkian AR
    Urologiia; 2013; (3):29-30, 32-3. PubMed ID: 23987045
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oral sildenafil for the treatment of Raynaud's phenomenon and digital ulcers secondary to systemic sclerosis.
    Gore J; Silver R
    Ann Rheum Dis; 2005 Sep; 64(9):1387. PubMed ID: 16100356
    [No Abstract]   [Full Text] [Related]  

  • 16. Reply: To PMID 24837446.
    Chen H; Weng Z
    Urology; 2014 Jul; 84(1):56. PubMed ID: 24837448
    [No Abstract]   [Full Text] [Related]  

  • 17. Editorial comment.
    Hanno P
    Urology; 2014 Jul; 84(1):56. PubMed ID: 24837446
    [No Abstract]   [Full Text] [Related]  

  • 18. Management of digital vasculopathy in systemic sclerosis: benefits of multiple courses of endothelin-1 receptor antagonists.
    Ngcozana T; Ong V; Denton CP
    BMJ Case Rep; 2014 Mar; 2014():. PubMed ID: 24682137
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Fast and efficient healing of scleroderma-associated acral ulcers with sildenafil].
    Friedrichson E; Rehberger P; Fuhrmann JT; Walz F; Meurer M; Pfeiffer C
    Hautarzt; 2008 Mar; 59(3):230-2. PubMed ID: 17618409
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Successful treatment of systemic sclerosis-related digital ulcers and sarcoidosis with endothelin receptor antagonist (bosentan) therapy.
    Tillon J; Hervé F; Chevallier D; Muir JF; Levesque H; Marie I
    Br J Dermatol; 2006 May; 154(5):1000-2. PubMed ID: 16634913
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.